Detection of occult bone metastases can be critical in determining the management of patients with renal cell carcinoma, especially when standard of care imaging techniques test negative.  ¹⁸F-NaF PET/CT is significantly more sensitive at detecting renal cell carcinoma (RCC) skeletal metastases than conventional than bone scintigraphy or computed tomography (CT), according to an article published online ahead of print in the Annals of Oncology. {read more here}